|
|
|
World Drug Safety Congress Europe 2008
Venue: Hilton London Paddington, United Kingdom
Conference:
Day 1
17 Sept 8am - 5:30pm
Day 2
18 Sept 8am - 5:30pm
Workshops: 16 and 19 September
› Add this to my calendar
|
|
|
|
Sponsorship and exhibition opportunities
The World Drug Safety Congress is where your clients will come to look for solutions you can provide.
The World Drug Safety Congress aims to attract the biggest gathering of drug safety professionals, businesses and thought leaders to assemble in 2008. How are you going to make sure you stand out from the crowd? Invest in the event, your company’s future; and make sure your clients know who you are.
» Find out more
|
Oracle Health Sciences
|
|
 Oracle is a leading strategic software solutions provider to the health sciences industry. Oracle Health Sciences helps pharmaceutical, biotechnology, medical device, and healthcare organizations become the most successful in the world by offering the most innovative products and services that deliver the most compelling customer and shareholder value. Addressing industry requirements, Oracle provides comprehensive solutions including clinical trial management and analysis, electronic data capture, adverse event reporting and pharmacovigilance, and healthcare interoperability. Oracle partners with health sciences industry leaders – including 20 of the top 20 life sciences companies and 10 of the top 12 Fortune Global 500 healthcare organizations – to prevent and cure disease and enhance quality of life.
www.oracle.com
|
|
Phase Forward
|
|
 Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. The company offers proven solutions for electronic data capture (InForm™), phase I clinic automation (LabPas™), clinical data management (Clintrial™), clinical trials signal detection (CTSD™), strategic pharmacovigilance (Empirica Signal™) and Signal Management, adverse event reporting (Empirica Trace™) and applied data standards (WebSDM™). In addition, the company provides services in the areas of application implementation, hosting and validation, data integration, business process optimization, safety data management and industry standards. Phase Forward’s products and services have been utilized in over 10,000 clinical trials involving more than 1,000,000 clinical trial study participants at over 280 organizations and regulatory agencies worldwide including: AstraZeneca, Boston Scientific, Dana-Farber Cancer Institute, Eli Lilly, the U.S. Food and Drug Administration, GlaxoSmithKline, Harvard Clinical Research Institute, Merck Serono, Novartis, Novo Nordisk, PAREXEL International, Procter & Gamble, Quintiles, sanofi-aventis, Schering-Plough Research Institute, Servier, Tibotec and the U.K. Medicines and Healthcare Products Regulatory Agency. Additional information about Phase Forward is available at
www.phaseforward.com
|
|
PRA International
|
|
 PRA International is a leading, global clinical development organization, with over 3,600 employees located in 30 offices across six continents. As a full-service CRO, PRA offers a broad array of services encompassing the entire spectrum of clinical development programs, from filing of Investigational New Drug (IND) and similar applications to product registration and post-marketing surveillance.
PRA’s Safety & Risk Management group has a strong team of 100+ employees based in Europe, North America and Asia. Safety and risk management play an important role in drug development and as such, you need to find the right partner. PRA has the tools and know-how to plan and implement proper safety procedures throughout your product’s lifecycle. Partnering with PRA gives you access to PRA's Drug Safety Centers and the skills of our in-house experts.
PRA's Safety and Risk Management department has the knowledge, expertise and experience to deliver the following services:
- Generation/review of Safety Development, Pharmacovigilance and Risk Management Plans,
- Conduct of Risk Management Programs/RiskMAPs
- Risk assessments during development and post-authorization,
- SAE/ADR Management
- Medical Monitoring
- Annual/Periodic Safety Updates
- Data Monitoring & Endpoint Adjudication Committee support
- Data Pooling & Analysis,
- Integrated Analyses of Safety/Efficacy
Contact PRA via endpoints@praintl.com or on the Internet at: www.praintl.com
|
|
Cerner Corporation
|
|
 Cerner is one of the leading global supplier of healthcare information technology. Around the world, pharmaceutical, biotechnology and healthcare organizations turn to Cerner for our powerful, intuitive solutions that enhance clinical and financial outcomes. We offer a broad array of solutions, services and data capabilities that bring the power of health information technology to our Life Sciences’ clients.
To learn more, please visit www.cerner.com/lifesciences.
|
|
Fulcrum Pharma
|
|
 Fulcrum Pharma is a professional service company providing clients with expert solutions for the development of therapeutic products. We offer a range of services including:
- Consulting: Providing global insight and advice on product development and registration strategy from discovery to post-approval
- Development: Supplying integrated development expertise to fast-track product development, assure quality, and maximise return on investment
- Regulatory: Possessing global regulatory expertise to streamline submission management and achieve faster product approval
- Safety: Offering global pharmacovigilance and risk management expertise to ensure products comply with ever-increasing safety requirements
Our goal is to help clients bring therapeutic products to the market in a resource-efficient and timely manner.
www.fulcrumpharma.com
|
|
Satyam
|
|
 Satyam (NYSE: SAY), a leading global business and information technology services company, delivers consulting, systems integration, and outsourcing solutions to clients in 20* industries and 66* countries.
Satyam leverages deep industry and functional expertise, leading technology practices, and an advanced, global delivery model to help clients transform their highest-value business processes and improve their business performance. The company’s 51,643* professionals excel in engineering and product development, supply chain management, client relationship management, business process quality, business intelligence, enterprise integration, and infrastructure management, among other key capabilities.
Satyam development and delivery centers in the US, Canada, Brazil, the UK, Hungary, Egypt, UAE, India, China, Malaysia, Singapore, and Australia serve 670* clients, including more than one-third of the Fortune 500.
For more information, see www.satyam.com.
*As of June 30, 2008
|
|
UBC
|
|
 UBC is a global pharmaceutical services organization that combines deep scientific knowledge with broad operational expertise to meet the growing demands for strategic execution of post approval programs.
Our focus is on generating real-world data to support the development and commercialization of medical products for emerging and established life science companies.
We partner with our clients to offer services in scientific research and strategic consulting, late stage clinical development, post-approval registries and drug safety, data integration and analysis, clinical technologies, investigator services and medical education, patient recruiting, and market access services. UBC’s industry-leading risk management and epidemiology experts help clients appropriately balance the benefits and risks of innovative medicines and medical technology.
UBC specializes in offering innovative ways to study drugs and devices with an emphasis on science, strategy, and execution.
www.unitedbiosource.com
|
|
|
|
|
|
